Acquisition of Services for the Manufacture of Clinical Grade Lentiviral Vector Encoding GPC2-CAR

Awarded Limited / Sole Source Justification Posted

Solicitation number
75N91024P00623
Agency
Set-aside
No set-aside

Opportunity facts

Contract number
75N91024P00623 Federal contract award
Place of performance
Hamilton, Alabama, United States

Notice details come from SAM.gov. Updated .

About this opportunity

This Limited / Sole Source Justification Notice is for the acquisition of services to manufacture clinical grade lentiviral vector encoding GPC2-CAR for the National Cancer Institute, a component of the Department of Health and Human Services National Institutes of Health. The contractor must accept the Government's lentiviral vector construct and produce the lentiviral product within 6 months in compliance with GMP and FDA regulations, as well as perform long-term stability tests. Market research identified only one vendor capable of meeting the Government's requirements as outlined in the Statement of Work. The contract was awarded on August 15, 2024 under Solicitation Number 75N91024P00623 to an unknown vendor, but the total estimated dollar value and performance period are not provided.

Notice text

Awarded contract 75N91024P00623 to unknown vendor for unknown amount on 2024-08-15.

Files

Similar open opportunities

Opportunity Agency Set-aside Responses due
iPSC Culture and Differentiation Bethesda, Maryland 20892, United States · NAICS 325414 Office of Logisitics and Acquisition Operations No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors